Previously, tamoxifen (TAM) has been shown to induce apoptosis through elevation of intracellular Ca 2+ in HepG2 human hepatoblastoma cells. In this study we investigated the role of reactive oxygen species (ROS) in the TAM-induced apoptosis, and interrelationship between intracellular Ca 2+ and ROS. TAM induced a slow and sustained increase in intracellular ROS level. An antioxidant, N-acetylcysteine significantly inhibited both ROS production and apoptosis induced by TAM, suggesting that ROS may play an essential role in the TAM-induced apoptosis. In a time frame ROS generation followed intracellular Ca 2+ increase, and the extracellular and intracellular Ca 2+ chelation with EGTA and BAPTA/AM, respectively, completely inhibited the TAMinduced ROS production, indicating that intracellular Ca 2+ may mediate the ROS generation. Inhibitors of NAD(P)H oxidase, diphenylene iodonium, phenylarsine oxide and neopterine, significantly blocked the TAM-induced ROS generation and apoptosis, implying that this oxidase may act as a source enzyme for the production of ROS. These results suggest that non-phagocytic NAD(P)H oxidase may play a novel role as a mediator of the apoptosis associated with intracellular Ca 2+ in HepG2 cells. Cell Death and Differentiation (2000) 7, 925 ± 932.
Introduction
Tamoxifen (TAM) has been used to treat breast cancer, 1 with the potential for application as a cancer-preventing agent. 2 Although the antiestrogenic properties of TAM appear to be responsible for the anticancer activities of TAM in breast cancer, 3 the exact mechanisms of the actions of TAM are not yet clearly understood.
Apoptosis is a highly organized cell death process characterized by early and prominent condensation of nuclear chromatin, loss of plasma membrane phospholipid asymmetry, activation of proteases and endonucleases, enzymatic cleavage of the DNA into oligonucleosomal fragments, and segmentation of the cells into membranebound apoptotic bodies. 4 TAM has been shown to induce apoptotic cell death in many types of tumor cells regardless of existence of estrogen receptor (ER). 5 ± 8 Although the signal transduction mechanisms by which TAM induces apoptosis in ER-negative tumor cells are essentially unknown, it is found to be associated with activation of the transcription factor NF-kB, 7 or increased c-myc expression. 8 Recently, we have also reported that TAM induces apoptosis through the activation of intracellular Ca 2+ signal in ER-negative HepG2 human hepatoblastoma cells. 9 Accumulating evidence implies that intracellular Ca 2+ is commonly involved in the mechanism of apoptosis. 10 One of the targets for elevated intracellular Ca 2+ is the activation of the Ca 2+ -dependent protein kinases and phosphatases 11 which has been seen during apoptosis. 12 Direct activation of the Ca 2+ -dependent proteinase may represent another target for intracellular Ca 2+ action in apoptosis. 13 Ca 2+ /Mg 2+ -dependent endonuclease whose activation results in DNA fragmentation, the most characteristic biochemical feature of apoptosis, 14 and Ca 2+ -dependent transglutaminase which is highly activated in apoptotic cells, 15 also appear to be a target for Ca 2+ action. 16, 17 The in vitro antitumor actions of TAM have been explained by its ability to perturb intracellular Ca 2+ homeostasis. 9, 18 In HepG2 cells we have found that TAM induced a sustained Ca 2+ influx through activation of non-specific cation channels leading to apoptotic cell death. 9 There are numerous reports showing that oxidants kill cells by inducing apoptosis. 19 ± 21 In addition, oxidative stress is proposed as a common mechanism by which various agents induce apoptosis. 22 Recently, reactive oxygen species (ROS) have also been demonstrated to play an essential role in apoptosis induced by TAM in ERnegative human cancer cells. 7, 23 Intracellular Ca 2+ appears to be essential for generation of ROS in many cell types, including mitogen-activated human lymphocytes 24 and growth factor-stimulated human keratinocytes. 25 Extracellular Ca 2+ influx is necessary for ROS generation during respiratory burst in human neutrophils. 26 ROS production stimulated by excitotoxin is dependent on intracellular Ca 2+ in rat cerebellar granule cells. 27 Based on these previous findings, we hypothesized that TAM induces apoptosis through ROS generation mediated by elevated intracellular Ca 2+ . To verify this hypothesis, in this study we investigated (i) the role of ROS in the TAMinduced apoptosis in ER-negative HepG2 human hepatoblastoma cells, (ii) the cause-and-effect relationship between intracellular Ca 2+ and ROS acting as a mediator of apoptosis, and (iii) the potential sites of ROS generation induced by TAM in the HepG2 cells.
Results

Induction of apoptotic cell death by TAM
We have previously reported that TAM induced apoptotic cell death in time-and concentration-dependent manners in the HepG2 cells. 9 In this study we confirmed the apoptotic activity of TAM in the cells. TAM induced DNA fragmentation in a concentration-dependent manner studied by agarose gel electrophoresis as depicted in Figure 1A . This effect of TAM was prominent at the concentration of 30 mM. TAM also induced loss of phospholipid asymmetry, resulting in appearance of phosphatidylserine on the outer layer of the plasma membrane detected by annexin-V binding, as depicted in Figure 1B . Furthermore, TAM induced apoptosis in a time-related manner tested by flow cytometry by determining hypodiploid DNA content stained with PI 28 as shown in Figure 1C . Taken together, these results indicate that TAM induced apoptotic cell death in the HepG2 cells.
Role of ROS in the TAM-induced apoptosis
To determine the role of ROS in the TAM-induced apoptosis of HepG2 cells, we first examined whether TAM generates ROS assessed by 2',7'-dichlorofluorescin diacetate (DCFH) fluorescence. 29 As shown in Figure 2A , TAM (30 mM) induced a slow and sustained increase in intracellular ROS level, and this increase continued for at least 1 h, depicted in Figure 2B . The TAM-generated ROS was completely inhibited by an antioxidant, N-acetylcysteine (NAC) (50 mM) as illustrated in Figure 2B . To determine the role of ROS in the TAM-induced apoptosis, we investigated whether NAC could suppress the apoptosis induced by TAM. As shown in Figure 2C , NAC (50 mM) significantly lowered hypodiploid DNA content induced by TAM, indicating that ROS may be involved in the mechanism of the TAM-induced apoptosis in the HepG2 cells. In the experiments of (B) cells were treated for 48 h with or without TAM (30 mM). Cells were stained with Annexin-V-FLUOS and analyzed by flow cytometry. In the experiments of (C) the cells were incubated with TAM (30 mM) for each designated time. The number of apoptotic cells was measured by flow cytometry as described in text. The region to the left of the G 0 /G 1 peak, designated A 0 , was defined as cells undergoing apoptosis-associated DNA degradation. 28 In bar graphs the data represent the mean values of four replications with bars indicating S.E.M. *P50.05 compared to control Role of intracellular Ca 2+ on the ROS generation and apoptosis induced by TAM Next, we investigated the possible interrelationship between intracellular Ca 2+ and ROS in the apoptosis-inducing activity of TAM. Time-dependent changes in the levels of intracellular Ca 2+ and ROS induced by TAM (30 mM) was compared with each other. Intracellular Ca 2+ increase preceded the ROS generation as shown in Figure 3A . In addition, the TAMinduced ROS production was completely prevented by treatment with ethylene glycol-bis-(aminoethyl ether)N,N,N, N-tetraacetic acid (EGTA) (1 mM) and bis-(o-aminophenoxy)-ethane-N,N,N,N-tetraacetic acid/acetoxymethyl ester (BAP-TA/AM) (1 mM), an extracellular and intracellular Ca 2+ chelator, respectively, as illustrated in Figure 3B . These results imply that intracellular Ca 2+ may act as an early signal for the production of ROS by TAM.
Role of NAD(P)H oxidase in the TAM-induced ROS generation and apoptosis
To clarify the sites of the TAM-induced ROS production, we investigated the effects of various drugs that inhibit the mitochondrial respiratory chain enzymes or non-mitochondrial ROS-generating enzymes, on the TAM-induced ROS generation and apoptosis. The results were summarized in Table 1 . The effects of TAM (30 mM) on the ROS level and apoptosis were not significantly altered either by inhibition of mitochondrial electron transport with inhibitors of Complex I, succinate dehydrogenase or Complex III (10 mM rotenone, 5 mM malonate, rotenone+malonate, and 5 mM antimycin A, respectively) or by the mitochondrial uncoupler, carbonylcyanide-p-(trifluoromethoxy)phenylhydrazone (FCCP) (0.1 mM). These mitochondrial enzyme inhibitors did not have a significant influence on the basal level of ROS and apoptosis, except that antimycin A and FCCP significantly increased only the basal level of ROS. These results indicate that mitochondria may not be the site of ROS production induced by TAM.
Thus, we examined whether non-mitochondrial ROSgenerating enzymes contribute to the TAM-induced ROS production. The effects on the ROS and apoptosis of inhibitors of enzymes which can potentially generate ROS, cyclooxygenase, cytochrome P-450, nitric oxide synthase, xanthine oxidase and ribonucleotide reductase (100 mM indomethacin, 500 mM metyrapone, 100 mM N G -monomethyl-L-arginine (NMMA), 100 mM allopurinol and 1.5 mM hydroxyurea, respectively) were tested. The results showed that all drugs tested did not significantly influence the TAMinduced ROS increase and apoptosis, implying that these enzymes may not be actively involved in the TAM effects. In contrast, inhibitors of membrane-bound NAD(P)H oxidase, 5 mM diphenylene iodonium (DPI), 30 10 mM phenylarsine oxide (PAO) 31 and 100 mM D-(+)-neopterine (NEO), 32 significantly suppressed both the ROS generation and apoptosis induced by TAM as shown in Figure 4A ,B, respectively. As a matter of fact, the activity of NAD(P)H oxidase similar to that found in neutrophils, has been detected in the HepG2 cells. 33 Thus, these results strongly suggest that non-phagocytic NAD(P)H oxidase may act as a major site of ROS generation induced by TAM in the HepG2 cells.
Discussion
Although anti-cancer actions of TAM have been originally known to be due to its ability to inhibit ER, 34 TAM appears to be effective for many cancer cells in which ER is not expressed. 1 Previously, we have reported that TAM induces apoptotic cell death in ER-negative HepG2 human hepatoma cells, 9 which was confirmed in this study by DNA fragmentation assay through gel electrophoresis, measurement of hypodiploid DNA contents through flow cytometry and detection of cell-surface phosphatidylserine with annexin-V conjugates (Figure 1) . However, the exact mechanism of this non-genomic action of TAM remains unclear.
The mechanism of the induction of apoptosis by TAM in ER-negative tumor cells is supposed to be related to nongenomic actions of TAM, for example, inhibition of calmodulin kinase 35 or protein kinase C. 36 In the HepG2 cells the TAM-induced apoptosis seems to be mediated by intracellular Ca 2+ whose involvement in apoptosis has been extensively studied in various cell types. 9, 37 The results of this study suggest that ROS may also be involved in the TAM-induced apoptosis, since TAM generated ROS (Figure 2A,B) , and an antioxidant NAC significantly inhibited apoptosis induced by TAM ( Figure 2C ). Since interplay between intracellular Ca 2+ and ROS has been shown in many cellular systems, 38, 39 we hypothesized that there is a cause-and-effect relationship between intracellular Ca 2+ and ROS as a mediator of the TAMinduced apoptosis in the HepG2 cells. The results of the present study strongly suggest that ROS may be a downstream signal of elevated intracellular Ca 2+ . The TAM-induced generation of ROS was preceded by elevation of intracellular Ca 2+ in a time frame ( Figure 3A ), and completely inhibited by reducing extracellular Ca 2+ concentration with a nominal Ca 2+ -free medium containing EGTA and chelating intracellular Ca 2+ with BAPTA/AM ( Figure 3B ).
The major biological process leading to oxygen-derived ROS generation is electron transport associated with mitochondrial membranes. 40 In mitochondria complex III can generate ROS, especially in the presence of compounds that prolong the lifetime of ubisemiquinone. 14 Therefore, if the site of the TAM-induced ROS increase is mitochondria, mitochondrial inhibitors that suppress the formation of ubisemiquinone at complex III should abolish the increase in ROS seen by treating with TAM. However, rotenone and malonate (inhibitors of NADH dehydrogenase and succinate dehydrogenase, respectively) treated alone or together, did not have a significant influence on the TAM-induced ROS generation and apoptosis ( Table 1) . As expected, antimycin A, a complex III inhibitor augmented the basal production of ROS probably through prolonging the lifetime of ubisemiquinone, 41 but it did not enhance the ROS production and apoptosis induced by TAM (Table 1 ). In addition, FCCP, a mitochondrial uncoupler also increased the basal ROS level, which is consistent with the results of other studies, 42 but it had no effect on the TAM-induced ROS production and apoptosis. Taken together, these results strongly suggest that mitochondria may not be the site of ROS generation induced by TAM.
ROS can also be generated by non-mitochondrial sites. ROS appear to be produced by the microsomal enzyme, cytochrome P-450, and numerous catalytic cytosolic enzymes, including cyclooxygenase, nitric oxide synthase, xanthine oxidase and ribonucleotide reductase. 43 The specific inhibitors of these enzymes (500 mM metyrapone, 100 mM indomethacin, 100 mM NMMA, 100 mM allopurinol and 1.5 mM hydroxyurea, respectively) were not effective for preventing the TAM-induced ROS production and apoptosis ( Table 1 ), demonstrating that these nonmitochondrial enzymes may not be involved in the ROS generation by TAM in the HepG2 cells.
The membrane-bound NADPH oxidase is known to produce ROS during the respiratory burst in neutrophils. 44 The enzyme has also been involved in the ROS-mediated apoptosis in human leukemia cells. 45 The activation of this enzyme proceeds through a multistep assembly at the plasma membrane of several components including the two subunits of cytochrome b 558 (p22 phox and gp91 phox ), the small GTPbinding proteins (Rac and Rap1A), and the cytosolic factors In these experiments DPI (5 mM). PAO (10 mM) and NEO (100 mM) were used. These drugs were given 10 min and 30 min before TAM application in the experiments of (A) and (B), respectively. *P50.05 compared to control. # P50.05 compared to TAM alone
Cell Death and Differentiation NAD(P)H oxidase in tamoxifen-induced apoptosis YS Lee et al (p40 phox , p47 phox and p67 phox ). 44, 46 Recently, these components have also been detected and functionally active in nonphagocytic cells, including endothelial cells, 47 vascular smooth muscle cells, 48 neuroepithelial bodies of the lung 49 and type I cells of the carotid body. 50 Interestingly, this enzyme acts as a main system to produce ROS during oxidative stress condition in vascular cells. 51, 52 HepG2 cells used in this study have been shown to express these components found in the NADPH oxidase complex of neutrophils. 53, 54 This enzyme system appears to be a major source of ROS produced particularly in association with hypoxia-induced erythropoietin expression in the HepG2 cells. 53 Therefore, we examined whether the membrane-bound NAD(P)H oxidase contributes to the TAM-induced ROS generation. The significant suppression of the TAM-induced production of ROS ( Figure 4A ) and apoptosis ( Figure 4B ) by various inhibitors of the enzyme (DPI, PAO and NEO) suggest that the membrane-bound NAD(P)H oxidase may be actively involved in the production of ROS induced by TAM.
Currently, we do not know the exact mechanism by which TAM activates the NAD(P)H oxidase in the HepG2 cells. However, antagonistic effects of Ca 2+ inhibitors on the TAM-induced ROS generation ( Figure 3B ) suggest involvement of intracellular Ca 2+ signal. Recently, Cool et al. 54 have demonstrated that in HepG2 cells Rac1, a small GTP binding protein is involved in the regulation of ROS production by the non-phagocytic NAD(P)H oxidase complex. In addition, Ca 2+ /CaM-dependent protein kinase-II has been demonstrated to phosphorylate and regulate Tiam1, 55 a Rac1-specific exchange factor. 56 Thus, although speculated, there is a possibility that elevated Ca 2+ by TAM activates Ca 2+ /CaM-dependent protein kinase-II, which in turn, activates Tiam1, leading to activation of Rac1. Moreover, Orie et al. 57 have recently found that Ca 2+ / CaM-dependent protein kinase-II is a common signaling component in the generation of ROS in human lymphocytes. The involvement of Ca 2+ /CaM-dependent protein kinase-II in the TAM-induced activation of NAD(P)H oxidase in the HepG2 cells remains to be elucidated in the future.
In conclusion, TAM induced apoptosis through generation of ROS in HepG2 human hepatoblastoma cells. TAM may activate NAD(P)H oxidase via increasing intracellular Ca 2+ concentration, which results in the production of ROS and apoptosis. However, since the concentration of tamoxifen used in this study (30 mM) may not be obtainable in vivo, one should consider it cautiously when these results may be interpreted as the mechanism of the actions of tamoxifen in vivo. Nevertheless, these results suggest that NAD(P)H oxidase may have a novel role in apoptotic cell death induced by TAM, an activator of intracellular Ca 2+ signal in the HepG2 cells.
Materials and Methods
Materials
The 
DNA isolation and electrophoresis
DNA isolation was done according to Hockenbery et al. 58 HepG2 cells were collected by centrifugation (2006g, 10 min), washed twice in phosphate buffered saline (PBS) (pH 7.4) and resuspended at a density of 4610 6 cells/400 ml in hypotonic lysing buffer (5 mM Tris, 20 mM EDTA, pH 7.4) containing 0.5% Triton X-100 for 30 min at 48C. The lysates were centrifuged at 13 0006g for 15 min at 48C. Fragmented DNA was extracted from the supernatant with phenolchloroform-isoamylalcohol, precipitated by addition of 2 volume of absolute ethanol and 0.1 volume of 3 mM sodium acetate, and treated with RNAse A (500 U/ml) at 378C for 3 h. The pattern of DNA fragmentation was visualized by electrophoresis in 1.8% agarose gel containing ethidium bromide and photographed under UV light.
Intracellular ROS measurement
Relative changes in intracellular ROS in the HepG2 cells were monitored using a fluorescent probe, DCFH-DA. 29 DCFH-DA diffuses through the cell membrane readily and is hydrolyzed by intracellular esterases to nonfluorescent DCFH, which is then rapidly oxidized to highly fluorescent DCF in the presence of ROS. The DCF fluorescence intensity is proportional to the amount of ROS formed intracelularly. 59 Cells were washed twice and resuspended at a concentration of 4610 5 cells/ml in Hank's solution. For loading DCFH-DA into the cells, cells were incubated with the dye for 2 h at a final concentration of 5 mM at 378C. Fluorescence (excitation wavelength set at 485 nm and the emission wavelength at 530 nm) was monitored in a well-stirred cuvette.
Intracellular Ca 2+ measurement
Aliquots of the HepG2 cells were washed in EBSS. Then, 5 mM Fura-2 was added, and the cells were incubated for 30 min at 378C. Unloaded Fura-2 was removed by centrifugation at 1506g for 3 min. Cells were resuspended at a density of 2610 6 cells/ml in Krebs-Ringer buffer containing 125 mM NaCl, 5 mM KCl, 1.3 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , 5 mM NaHCO 3 , 25 mM HEPES, 6 mM glucose and 2.5 mM probenecid (pH 7.4). Fura-2-loaded cells were maintained at 258C for 90 min before fluorescence measurement. For each experiment, 0.5 ml aliquot of Fura-2-loaded cells was equilibrated to 378C in a stirred quartz cuvette. Fluorescence emission (510 nm) was monitored with the excitation wavelength cycling between 340 and 380 nm using a Hitachi F4500 fluorescence spectrophotometer. At the end of an experiment, fluorescence maximum and minimum values at each excitation wavelength were obtained by lysis of cells with 20 mg/ ml digitonin (maximum) and then adding 10 mM EGTA (minimum). With the maximum and minimum values, the 340 : 380 nm fluorescence ratios were converted into free Ca 2+ concentrations using a software, F-4500 Intracellular Cation Measurement System, provided by Hitachi.
Flow cytometric analysis of apoptosis
For flow cytometry analysis, HepG2 cells were collected and washed twice with PBS buffer (pH 7.4). After fixing in 80% ethanol for 30 min, cells were washed twice, and resuspended in PBS buffer (pH 7.4) containing 0.1% Triton X-100, 5 mg/ml PI and 50 mg/ml ribonuclease A for DNA staining. Cells were then analyzed by a FACScan (BIO-RAD, Hercules, CA, USA). At least 20 000 events were evaluated. All histograms were analyzed using WinBryte software (BIO-RAD, Hercules, CA, USA) to determine percentage of nuclei with hypodiploid content indicative of apoptosis. 28 The normal lipid organization of the plasma membrane is altered soon after apoptosis is initiated. Thus, annexin-V binding was also employed as an indicator of apoptosis 60 to demonstrate the loss of phospholipid asymmetry and the presence of phosphatidylserine on the outer layer of the plasma membrane. It was analyzed using a commercial kit (Boehringer Mannheim Biochemicals, Mannheim, Germany). Cells were washed in cold PBS, and resuspended in binding buffer. A portion of cell suspension (500 ml) was exposed to Annexin-V-FLUOS. The cells were gently vortexed, incubated at room temperature for 20 min in the dark, and then analyzed by FACScan within 1 h of staining.
Data analysis
All experiments were performed four times. Data were expressed as mean+standard error of the mean (S.E.M.) and were analyzed using one way analysis of variance (ANOVA) and Student-Newman-Keul's test for individual comparisons. P values less than 0.05 are considered statistically significant.
